Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)

ConditionEpilepsy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-60

SponsorKayela Arrotta

About this trial

The goal of this clinical trial is to test if cognitive interventions in those with diagnosed epilepsy can help lessen cognitive lapses and improve overall brain health.

Participants will participate in weekly, virtual group sessions led by a neuropsychologist for 12 weeks. After the 12-week mark, participants will be asked to practice what they learned for 9 more months. Participants will be asked to complete online questionnaires at certain times during the study. Researchers will compare this intervention group to another group that did not get the intervention to see if the intervention improves brain health. Participation in each of these groups will be randomly assigned. Participation in the study will last for one year.

Eligibility criteria

Qualifiers

Potential patients will be identified if they have been, or are scheduled to be seen, either in-person or virtually for a clinical visit within the Cleveland Clinic Epilepsy Center

Adults, aged 18-60 years old, with diagnosed epilepsy

Subjective cognitive difficulties based on patient self-report or objective cognitive deficits as determined by neuropsychological tests

Able to independently provide informed consent

Disqualifiers

Patients with a current diagnosis of non-epileptic or psychogenic seizures

Any patient that has engaged in any form of cognitive rehabilitation/intervention within the last 6 months

Patients currently enrolled in another interventional study for epilepsy at the time of enrollment

Anticipated or scheduled epilepsy surgery within 6 months

Trial design

Treatments tested in this trial

Cognitive Intervention

Treatment groups

170 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Kayela Arrotta

Lead sponsor

The Cleveland Clinic

Sponsor institution

Source ClinicalTrials.gov